Trial Profile
The Use of Intravascular Paclitaxel for the Treatment of Upper-Arm Arteriovenous Access Fistula Stenosis: A Randomized Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Heparin
- Indications Vascular restenosis
- Focus Therapeutic Use
- Acronyms PaciFIST-1
- 14 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 May 2015 New trial record